Related Experiment Videos
Predictive ADMET studies, the challenges and the opportunities.
Andrew M Davis1, Robert J Riley
1Department of Physical and Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK. Andy.davis@astrazeneca.com
Current Opinion in Chemical Biology
|August 4, 2004
Summary
Predictive ADMET modeling uses structural data to forecast drug properties, aiding in the design of safer, more effective medicines. Challenges remain due to data limitations and model complexities.
Area of Science:
- Computational chemistry and drug discovery.
- Pharmacology and toxicology.
Background:
- Predictive Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) is a rapidly growing field in drug discovery.
- Utilizing large datasets of structure-activity relationships is key to developing computational models.
Purpose of the Study:
- To review the current state, including failures, successes, and future opportunities in predictive ADMET.
- To explore the use of computational models for predicting human ADMET properties from in vitro and in vivo data.
Main Methods:
- Building computational models that correlate chemical structures with ADMET responses.
- Leveraging large databases of existing ADMET data linked to compound structures.
Main Results:
- Predictive models aim to design and forecast compounds with enhanced ADMET properties.
- The approach allows for prediction of human ADMET from human in vitro and animal in vivo measurements.
Conclusions:
- Current predictive ADMET methods are constrained by data availability, modeling techniques, and system understanding.
- Despite limitations, predictive ADMET holds significant promise for optimizing drug design and safety.